Status:
COMPLETED
Seroepidemiology of Viral Hepatitis in Hong Kong
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Viral Hepatitis
Eligibility:
All Genders
Brief Summary
Immunisation policies have strong influences on the epidemiology of hepatitis A and B infection. In Hong Kong, vaccines against both viruses have been available through different channels and programm...
Eligibility Criteria
Inclusion
- residents normally living in Hong Kong
- living in domestic households randomly selected from Building Groups
- Any age, while subjects below the age of 18 would require informed consent of their guardians for participation
- Any gender
Exclusion
- unable to understand written Chinese or English,
- failure to give consent for participation
- living in institution or non-domestic housing,
- foreign domestic helpers,
- normally living in Hong Kong
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2022
Estimated Enrollment :
2888 Patients enrolled
Trial Details
Trial ID
NCT04371276
Start Date
September 1 2018
End Date
May 31 2022
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong, China